Opinion|Videos|February 2, 2026

Defining Clear Skin Remission in Psoriasis Care

Explore the evolving concept of on-treatment remission in psoriasis management and its impact on patient care and quality of life.

In this segment, experts define on-treatment remission as achieving completely clear skin, measured as zero Body Surface Area (BSA) or a clear Investigator Global Assessment (IGA) score, for at least six consecutive months while on therapy. Remission may require ongoing systemic treatment, similar to managing other chronic conditions.

The panel agrees this six-month benchmark is realistic and aligns with patient expectations for total clearance. Crucially, they note that while clear skin is the primary target, a complete assessment must include high-impact areas and patient-reported symptoms. Doctors emphasize directly asking patients about burdens in sensitive areas like the scalp, genitals, palms, and soles, as well as joint pain, to ensure treatment improves overall quality of life, not just visible plaque count.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.